1. Home
  2. AXGN vs CCO Comparison

AXGN vs CCO Comparison

Compare AXGN & CCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AXGN
  • CCO
  • Stock Information
  • Founded
  • AXGN N/A
  • CCO 1995
  • Country
  • AXGN United States
  • CCO United States
  • Employees
  • AXGN N/A
  • CCO N/A
  • Industry
  • AXGN Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • CCO Advertising
  • Sector
  • AXGN Health Care
  • CCO Consumer Discretionary
  • Exchange
  • AXGN Nasdaq
  • CCO Nasdaq
  • Market Cap
  • AXGN 538.3M
  • CCO 576.2M
  • IPO Year
  • AXGN N/A
  • CCO 2005
  • Fundamental
  • Price
  • AXGN $12.00
  • CCO $1.22
  • Analyst Decision
  • AXGN Strong Buy
  • CCO Buy
  • Analyst Count
  • AXGN 5
  • CCO 4
  • Target Price
  • AXGN $26.00
  • CCO $1.88
  • AVG Volume (30 Days)
  • AXGN 749.6K
  • CCO 5.0M
  • Earning Date
  • AXGN 08-07-2025
  • CCO 08-05-2025
  • Dividend Yield
  • AXGN N/A
  • CCO N/A
  • EPS Growth
  • AXGN N/A
  • CCO N/A
  • EPS
  • AXGN N/A
  • CCO N/A
  • Revenue
  • AXGN $194,520,000.00
  • CCO $1,512,570,000.00
  • Revenue This Year
  • AXGN $18.08
  • CCO $5.10
  • Revenue Next Year
  • AXGN $16.15
  • CCO $3.29
  • P/E Ratio
  • AXGN N/A
  • CCO N/A
  • Revenue Growth
  • AXGN 18.81
  • CCO 14.28
  • 52 Week Low
  • AXGN $7.34
  • CCO $0.81
  • 52 Week High
  • AXGN $21.00
  • CCO $1.88
  • Technical
  • Relative Strength Index (RSI)
  • AXGN 63.42
  • CCO 56.51
  • Support Level
  • AXGN $10.71
  • CCO $1.18
  • Resistance Level
  • AXGN $12.28
  • CCO $1.28
  • Average True Range (ATR)
  • AXGN 0.56
  • CCO 0.06
  • MACD
  • AXGN 0.30
  • CCO 0.00
  • Stochastic Oscillator
  • AXGN 89.08
  • CCO 65.79

About AXGN Axogen Inc.

Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically, economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, South Korea, and several other countries.

About CCO Clear Channel Outdoor Holdings Inc.

Clear Channel Outdoor Holdings Inc is a provider of out-of-home advertising solutions. The company offers advertisers an opportunity to reach mass audiences across various high-traffic public spaces, by using its diverse portfolio of assets including roadside billboards, street furniture, and airport displays. Its reportable segments are; America (U.S. operations excluding airports), Airports (U.S. and Caribbean airport operations), and Other. A majority of its revenue is generated from the America segment which generates revenue from the sale of advertising on printed and digital out-of-home advertising displays such as bulletins, posters, street furniture, and others. Geographically, the company generates maximum revenue from the United States followed by Singapore.

Share on Social Networks: